Webinar: Advancing Targeted Protein Degradation Research with Automated Western Blotting

Discover how automated assays are helping drive targeted protein degradation (TPD) research programs and Degrader development. During this webinar, the Bio-Techne® team will be joined by Dr Gary Allenby, CSO at Aurelia Bioscience, who will delve deeper into how their research team is utilizing automated Western blot systems from ProteinSimple™, a Bio-Techne brand.

Find out how high-throughput Western blotting platforms Wes™ and Jess™ from ProteinSimple can be used to rapidly and reproducibly quantify protein knockdown following treatment with Degraders.

Speakers

Dr. Gary Allenby, CEO, Aurelia Bioscience

Dr. Hannah Maple, Innovation Manager (Tocris, a Bio-Techne brand)

Dr. Carsten Lück, FAS and Science Manager, EMEA (ProteinSimple, a Bio-Techne brand)